Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jürgen Scholze, Angie Schaefer & Reinhold Kreutz. (2011) Safety and efficacy of olmesartan: an observational pooled-analysis of 156,682 hypertensive patients. Expert Opinion on Drug Safety 10:2, pages 185-196.
Read now
Read now
Articles from other publishers (3)
Olesia Bochar. (2020) PROTO-HORMONES LEVELS OF ADIPOSE TISSUE, INTERLEUKIN-6 AND INDICATORS OF DETOXIFYING FUNCTION OF THE LIVER IN PATIENTS WITH HYPERTENSION AND OBESITY COMBINED WITH NON-ALCOHOLIC FATTY LIVER DISEASE. Technology transfer: innovative solutions in medicine 4, pages 3-6.
Crossref
Crossref
G. Kourlaba, F. Gialama, K. Tsioufis & N. Maniadakis. (2016) A literature review to evaluate the clinical and economic value of olmesartan for the treatment of hypertensive patients. International Journal of Cardiology 221, pages 60-74.
Crossref
Crossref
Shunjing Ding, Jin Liu, Qiang Fu & Ying Zheng. (2013) Clinical effects of combined olmesartan medoxomil and amlodipine on clinic and ambulatory blood pressure in elderly patients with resistant hypertension. Archives of Gerontology and Geriatrics 57:3, pages 423-427.
Crossref
Crossref